Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grignon

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Prostate Cancer and Prostatic Diseases|December 7, 2005
Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinomaG Altinok, I J Powell, M Che, et al.
Oncogene|May 2, 1996
A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomasV Shridhar, S Rivard, R Shridhar, et al.
Urology|June 4, 1998
Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancerE L Gheiler, M V Tefilli, R Tiguert, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostateM V Pilepich, K Winter, M J John, et al.
Oncogene|October 1, 1994
High frequency of mutator phenotype in human prostatic adenocarcinomaX Gao, N Wu, D Grignon, et al.
Molecular Urology|February 24, 2001
Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate CancerM B Garnick, W R Fair, D Bostwick, et al.
The American Journal of Surgical Pathology|October 1, 1994
Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostateD G Bostwick, F Algaba, M B Amin, et al.
Human Pathology|August 1, 1993
Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinomaD G Bostwick, J Srigley, D Grignon, et al.
Human Pathology|August 1, 1994
Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostateD G Bostwick, F Algaba, M B Amin, et al.
Cancer Research|December 15, 1996
Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neckR Shridhar, V Shridhar, S Rivard, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Prostate Cancer and Prostatic Diseases|December 7, 2005
Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinomaG Altinok, I J Powell, M Che, et al.
Oncogene|May 2, 1996
A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomasV Shridhar, S Rivard, R Shridhar, et al.
Urology|June 4, 1998
Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancerE L Gheiler, M V Tefilli, R Tiguert, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostateM V Pilepich, K Winter, M J John, et al.
Oncogene|October 1, 1994
High frequency of mutator phenotype in human prostatic adenocarcinomaX Gao, N Wu, D Grignon, et al.
Molecular Urology|February 24, 2001
Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate CancerM B Garnick, W R Fair, D Bostwick, et al.
The American Journal of Surgical Pathology|October 1, 1994
Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostateD G Bostwick, F Algaba, M B Amin, et al.
Human Pathology|August 1, 1993
Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinomaD G Bostwick, J Srigley, D Grignon, et al.
Human Pathology|August 1, 1994
Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostateD G Bostwick, F Algaba, M B Amin, et al.
Cancer Research|December 15, 1996
Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neckR Shridhar, V Shridhar, S Rivard, et al.
Pageof 7